Can-Fite BioPharma (CANF) Non-Current Assets (2014 - 2026)
Can-Fite BioPharma's Non-Current Assets was $52,000 in Q2 2026, down 45.8% from $96,000 a year earlier.
Powered by 
Analysis
Can-Fite BioPharma (CANF) Non-Current Assets (2014 - 2026) Analysis & Trends
At the end of FY2025, Non-Current Assets at Can-Fite BioPharma came in at $74,000, down 46.4% from FY2024.
- Non-Current Assets shows a five-year compound annual growth rate of -9.7% (FY2020 to FY2025).
- In earlier years, Non-Current Assets was $138,000 in FY2024 (+70.4%), $81,000 in FY2023 (-35.7%), $126,000 in FY2022 (-31.9%) and $185,000 in FY2021 (+50.4%).
- The Q2 2026 figure marks the lowest quarterly Non-Current Assets since Q2 2019.
- Compared with a year earlier, Non-Current Assets was higher in two of the last four quarters, with an average decline of 4.9%.
- The best year-over-year quarter for Non-Current Assets over five years was Q4 2024 (growth of 70.4%); the worst was Q4 2025 (a decline of 46.4%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 14.88 Bn |
| 10 | Can-Fite BioPharma | 1.82 Mn | -17.88 Mn | - | 52,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 52,000.00 |
| Dec 31, 2025 | 74,000.00 |
| Jun 30, 2025 | 96,000.00 |
| Dec 31, 2024 | 138,000.00 |
| Jun 30, 2024 | 94,000.00 |
| Dec 31, 2023 | 81,000.00 |
| Sep 30, 2023 | 105,000.00 |
| Jun 30, 2023 | 123,000.00 |
| Mar 31, 2023 | 110,000.00 |
| Dec 31, 2022 | 126,000.00 |
| Sep 30, 2022 | 141,000.00 |
| Jun 30, 2022 | 157,000.00 |
| Mar 31, 2022 | 174,000.00 |
| Dec 31, 2021 | 185,000.00 |
| Sep 30, 2021 | 165,000.00 |
| Jun 30, 2021 | 127,000.00 |
| Mar 31, 2021 | 117,000.00 |
| Dec 31, 2020 | 123,000.00 |
| Jun 30, 2020 | 96,000.00 |
| Dec 31, 2019 | 1.03 Mn |
API Access
Can-Fite BioPharma Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=CANF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "CANF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=CANF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();